Antenatal prevention of cerebral palsy and childhood disability: is the impossible possible?
Stacey J ElleryMeredith KelleherPeta GrigsbyIrina BurdJan B DerksJon HirstSuzanne L MillerLarry S ShermanMary TolcosDavid W WalkerPublished in: The Journal of physiology (2018)
This review covers our current knowledge of the causes of perinatal brain injury leading to cerebral palsy-like outcomes, and argues that much of this brain damage is preventable. We review the experimental evidence that there are treatments that can be safely administered to women in late pregnancy that decrease the likelihood and extent of perinatal brain damage that occurs because of acute and severe hypoxia that arises during some births, and the additional impact of chronic fetal hypoxia, infection, inflammation, growth restriction and preterm birth. We discuss the types of interventions required to ameliorate or even prevent apoptotic and necrotic cell death, and the vulnerability of all the major cell types in the brain (neurons, astrocytes, oligodendrocytes, microglia, cerebral vasculature) to hypoxia/ischaemia, and whether a pan-protective treatment given to the mother before birth is a realistic prospect.
Keyphrases
- cerebral palsy
- preterm birth
- brain injury
- gestational age
- cerebral ischemia
- cell death
- subarachnoid hemorrhage
- oxidative stress
- pregnant women
- white matter
- low birth weight
- resting state
- endothelial cells
- pregnancy outcomes
- healthcare
- multiple sclerosis
- liver failure
- inflammatory response
- spinal cord
- emergency department
- respiratory failure
- cell therapy
- cell cycle arrest
- skeletal muscle
- early onset
- mesenchymal stem cells
- polycystic ovary syndrome
- cell proliferation
- breast cancer risk
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- adverse drug
- electronic health record
- current status